Zeguang Zheng

Zeguang Zheng

State Key Laboratory Of Respiratory Disease
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendations.

Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendations.

Journal: Chinese medical journal pulmonary and critical care medicine

Published: July 13, 2025

Respiratory physiological reactions during expiratory muscle training in patients with stable severe chronic obstructive pulmonary disease (COPD).

Respiratory physiological reactions during expiratory muscle training in patients with stable severe chronic obstructive pulmonary disease (COPD).

Journal: Physiology & behavior

Published: November 03, 2024

Multi-omics driven biomarker discovery and pathological insights into Pseudomonas aeruginosa pneumonia.

Multi-omics driven biomarker discovery and pathological insights into Pseudomonas aeruginosa pneumonia.

Journal: BMC infectious diseases

Published: September 29, 2024

A preliminary study on the effects of fecal microbiota transplantation on the intestinal microecology of patients with severe pneumonia during the convalescence period

A preliminary study on the effects of fecal microbiota transplantation on the intestinal microecology of patients with severe pneumonia during the convalescence period

Journal: Zhonghua wei zhong bing ji jiu yi xue

Published: June 12, 2023

Compliance and rehabilitation effects of Zheng's supine rehabilitation exercise performed at home among patients with chronic obstructive pulmonary disease: a retrospective study.

Compliance and rehabilitation effects of Zheng's supine rehabilitation exercise performed at home among patients with chronic obstructive pulmonary disease: a retrospective study.

Journal: Journal of thoracic disease

Published: May 18, 2023

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty.

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty.

Journal: Frontiers in medicine

Published: March 09, 2023

Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study.

Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study.

Journal: BMC infectious diseases

Published: December 23, 2022

Exploration of the minimal clinically important difference value of the 3-min simulated pedal motion in patients with chronic obstructive pulmonary disease: A self-controlled prospective clinical trial.

Exploration of the minimal clinically important difference value of the 3-min simulated pedal motion in patients with chronic obstructive pulmonary disease: A self-controlled prospective clinical trial.

Journal: The clinical respiratory journal

Published: November 27, 2022

Identification of genetic variants of the IL-22 gene in association with an altered risk of COPD susceptibility.

Identification of genetic variants of the IL-22 gene in association with an altered risk of COPD susceptibility.

Journal: The clinical respiratory journal

Published: July 09, 2021

Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial.

Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial.

Journal: Respiratory research

Published: September 01, 2020

Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice.

Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice.

Journal: Critical care (London, England)

Published: May 26, 2020

A protective polymorphism in MMP16, improved blood gas levels, and chronic obstructive pulmonary diseases: Family and two population-based studies.

A protective polymorphism in MMP16, improved blood gas levels, and chronic obstructive pulmonary diseases: Family and two population-based studies.

Journal: Human mutation

Published: October 16, 2019

Showing 1-12 of 31

Last Updated: 09/26/2026